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‡Muscle Contraction Group, School of
Physiology and Pharmacology, University
of Bristol, Bristol, United KingdomIt is generally known that muscle con-
traction is produced by cyclic interac-
tion of myosin heads (crossbridges)
of thick filaments with actin thin fila-
ments driven by ATP hydrolysis; a
conformational change in an attached
crossbridge produces a pulling force
on the thin filaments toward the center
of a sarcomere (1). The activation of
this contractile process in both cardiac
and skeletal muscles is regulated by
the intracellular calcium ion concen-
tration, [Ca2þ], and it operates via the
thin (actin) filament; when [Ca2þ]
rises, a muscle contracts, and when
[Ca2þ] falls, a muscle relaxes. Tropo-
nin (Tn) is a constituent protein of
thin filament and the protein to which
Ca2þ binds to accomplish this regu-
lation. Troponin has three subunits,
TnC, TnI, and TnT. When calcium is
bound to specific sites on TnC, tropo-
myosin (Tm, another protein in the
thin filament) moves out of the way
of the active actin sites in thin filament,
so that crossbridges (molecular motors
organized in muscle thick filaments)
can attach to the thin filament and gen-
erate force and/or movement. In the
absence of calcium, tropomyosin pre-
vents this crossbridge operation, and
therefore muscles remain relaxed.
One of the long running mysteries of
the thin filament regulation is why there
are so many variants in the N-terminushttp://dx.doi.org/10.1016/j.bpj.2012.07.039
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0006-3495/12/09/0849/2 $2.00of TnT. There are muscle-specific
isoforms and alternate slice isoforms
(four splice variants in fast muscle).
Furthermore, why is the N-terminal
half of cardiac TnT such a hot spot for
cardiomyopathy mutations? At the
simple level, the view of TnT’s role
is to hold the troponin complex to
tropomyosin. More specifically, the
N-terminal part of TnT binds along
tropomyosin and stabilizes the Tm-
Tm-contacts between consecutive
Tms along the actin filament. This ex-
plains the structural role of TnT, but
not why different TnTs are needed;
tropomyosin isoforms, after all, do
not show the same tissue specificity.
aTm is the same in all striated muscle
with some variation in the amount of
b-Tm expressed. If the structural
role of TnT was this simple, how do
different Tn isoforms tune muscle
function and why do mutations in the
region have such a dramatic effect on
function?
The implication is that there must be
more to TnT and the standard view is
that it modulates the cooperativity of
the Tm on-off switch of muscle con-
traction. The work of Gollapudi et al.
(2), reported in this issue, gives the first
evidence that the N-terminus of cTnT
does modulate Tm behavior.
The N-terminus of cardiac troponin
T (cTnT) has a distinct N-terminus
extension (NTE) of ~32 amino acids,
rich in negative charges and highly
conserved in hearts of different mam-
malian species. This entire 32-amino-
acid segment is absent in both fast
and slow skeletal muscle TnT. The spe-
cific functional role of the NTE has
remained unclear despite previous
functional studies in which the cTnT
was replaced by skeletal TnT. The arti-
cle by Gollapudi et al. (2) addresses the
role of the specific NTE of cardiac TnT
using a transgenic mouse model ex-
pressing a recombinant chimeric cTnT
where the NTE was replaced with
the corresponding NTE of fast skele-
tal TnT. The results show that few
mechanical or biochemical parameters
are altered in skinned cardiac musclefiber, except the calcium sensitivity of
isometric force.
In detail, chemically skinned papil-
lary muscle fiber bundles isolated
from hearts of these transgenic mice
were used experimentally to determine
a range of dynamic and steady-state
mechanical and biochemical parame-
ters at different Ca2þ concentrations
and at two different sarcomere lengths;
a comparison is made between the
transgenic (cTnT with altered NTE)
and the nontransgenic (control) mouse
cardiac muscles with respect to a wide
range of physiological and biochemical
characteristics such as maximum iso-
metric force, stiffness, maximum short-
ening velocity, Ca-sensitivity of force,
ATPase, etc. Thus, Gollapudi et al., in
essence, tested the hypothesis that the
NTE of cTnT has a specific regulatory
role in cardiac muscle activation.
Their main (positive) finding is
shown in Fig. 5 in the article, and it
is that the Ca-sensitivity of steady
force development is higher in trans-
genic muscle; in other words, the
force versus pCa relation was shifted
to the left (low [Ca2þ]) in transgenic
muscle without the cardiac-specific
NTE. Equally, or even more important
results reported in the study are the
negative findings (no significant differ-
ence between transgenic and control
muscle) from control experiments;
thus, chimeric cTnT has no significant
effect on maximal Ca-activated force
and ATPase rate, stiffness, crossbridge
turnover rate, crossbridge detachment
rate, and maximum velocity of short-
ening (see article for details). Thus,
most of the other mechanistic and bio-
chemical characteristics that relate to
acto-myosin crossbridge cycle were
unaltered. It appears that when NTE is
altered it affects thin filament activation
system directly rather than indirectly
via myosin (crossbridge) operation.
Findings are discussed in relation
to the mechanism of thin filament acti-
vation via three states (i.e., blocked,
closed, and open state transition) as
850 Geeves and Ranatungapreviously reported in biochemical
studies (see McKillop and Geeves
(3)). Indeed, the results would sup-
port the hypothesis that the NTE
of cTnT modulates the blocked-to-
closed state transition of the thin fila-
ment via its impact on the underlying
allosteric/cooperative mechanisms, as
proposed from previous biochemical
experiments. Correlated with existent
structural data, this study therefore pro-
vides novel mechanistic insights by
which the unique NTE of cTnT pro-
duces regulation of cardiac myofila-
ment. As discussed in the article, the
findings may have a bearing on age-
and disease-related changes cTnT iso-
forms, perhaps even in human heart,
because functionally distinct cTnT iso-
forms are thought to be expressed dur-
ing development and during cardiac
muscle disease (see references in the
article).
Given the thoroughness of this ex-
perimental study, the findings reported
therein are clearly significant and con-
clusive and, as mentioned in the article,
they may well relate to age- and dis-
ease-related issues of the human heart
function. Nevertheless, several issues
remain, not the least of which is the
molecular mechanism whereby the
cardiac-specific N-terminal extension
of TnT alters the calcium sensitivity
of the thin filament. A recent article by
Manning et al. (4) suggests that there
is a correlation between the change
in flexibility of TnT1 (the N-terminal
half of TnT) induced by hypertro-Biophysical Journal 103(5) 849–850phic cardiomyopathy mutations and
the change in cooperativity of calcium
activation. This raises the possibility
that the TnT isoforms have specific
flexibility that is tuned to the cellular
isoforms of the thin filament. Is the
cardiac-specific extension part of this
story? The link between cardiomyopa-
thy mutations and protein flexibility is
also highlighted in a recent article on
tropomyosin (5). Given the close con-
tact between TnT1 and tropomyosin,
it is possible that flexibility is a prop-
erty of the Tm-TnT1 complex.
Inevitably, an in vitro study as that
reported here requires further confir-
mation for the in vivo situation.
First, these experiments are not
done exactly under physiological con-
ditions; for example, they were done
at 20C, a much lower temperature
than the core physiological tempera-
ture of ~37C in which the mammalian
heart functions in situ. Indeed, it is
known that the pCa-force relation is
shifted to the right (Ca-sensitivity of
thin filament decreased) with an in-
crease of temperature, probably in all
types of striated vertebrate muscle
(see Stephenson and Williams (6)). Al-
though this probably reflects a TnC
property, given the complexity and
lack of proper understanding at present
of temperature effects on muscle func-
tion, it might be one other control (neg-
ative) finding worth knowing.
Second, data presented here are
from steady-state measurements and
from skinned fibers. Although bothmuscles are striated, vertebrate heart
(cardiac muscle) operates as a constant
volume pump whereas skeletal mus-
cles operate as force and work pro-
ducers. It is also not clear whether the
function of the in situ heart as a muscu-
lar pump is altered in the transgenic
mouse, and hence, the functional sig-
nificance of cTnT NTE requires further
elucidation. These are issues for the
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